Trial intelligence / Profile preview

CellCept with Low vs Standard Dose Tacrolimus in Kidney Transplant

NCT00758602Phase 4Completed

Sponsor
Roche
Start
Sep 2008
Primary completion
Feb 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate mofetil in kidney transplant rejection, sponsored by Roche. Started Sep 2008; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00758602.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00758602.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call